The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

33 ARCH STREET, 26TH FLOOR, BOSTON MA 02110-1447, USA
Tel:
Work +1 617 406 6000
Fax:
Fax +1 617 406 6100
Web:
www.dlapiper.com

Matthew Holian

Tel:
Work +1 617 406 6009
Email:
Web:
www.dlapiper.com/en/us/people/h/holian-matthew-a/
DLA Piper LLP (US)

Work Department

Litigation, Arbitration and Investigations; Product Liability, Mass Torts and Product Stewardship; Life Sciences; Healthcare

Position

Partner; Global Co-Chair, Life Sciences Sector

Career

Matt Holian serves as the Global Co-Chair of DLA Piper's Life Sciences Sector. Matt's practice focuses on litigation, regulatory and enforcement challenges facing pharmaceutical and medical device companies. His litigation practice primarily involves serving as national counsel in complex, multi-jurisdictional product liability suits, for which DLA Piper's Product Liability and Mass Tort practice group has been recognized by Legal 500 as Tier 1 since 2014 and by Chambers as Band 2 or Band 3 since 2015. In those cases, Matt defends his clients from start to finish, beginning with litigation risk assessments before medications are approved and continuing through pretrial discovery, bellwether trials and, ultimately, resolution. Matt previously served as Co-Chair of its Pharmaceutical and Medical Device Product Liability sub-group. Matt also has litigated cases involving the False Claims Act, consumer fraud, trade secret misappropriation and commercial disputes relating to licensing agreements.

In addition to his litigation practice, Matt also has an active regulatory and enforcement practice, which includes conducting compliance investigations, counseling clients regarding research and development issues (including defending hundreds of claims asserted by patients in clinical trials) and advising life sciences and other clients on a wide range of emerging regulatory issues, such as product labeling, First Amendment challenges to promotional restrictions, real word evidence and value-based contracts.

Education

J.D., Stanford University; B.A., Harvard University


United States: Dispute resolution

Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

Within: Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

DLA Piper LLP (US) is headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and is one of the leading firms for high-profile product liability litigation and mass torts in the medical and pharmaceuticals sectors. Notable highlights include representing Medtronic and Covidien as co-national counsel in the hernia mesh litigation, and defending Pfizer and Wyeth Pharmaceuticals in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. In other work, the highly regarded Loren Brown in New York is acting for Pfizer alongside Boston-based Matthew Holian in an MDL involving claims that anti-coagulant medication Eliquis causes bleeding. Cara Edwards in New York is also recommended. In January 2018, the team welcomed Stephen Matthews and Amy Rubenstein from Porzio, Bromberg & Newman and Schiff Hardin LLP respectively; in February 2018, Matt Nickel and Mike Moore joined from Dentons.

[back to top]

Product liability, mass tort and class actions: toxic tort - defense

Within: Product liability, mass tort and class actions: toxic tort - defense

The product liability and mass torts practice at DLA Piper LLP (US) is headed by Christopher Campbell and specializes in chemical exposure litigation. The team is defending e-cigarettes manufacturer NJOY in a civil action alleging that vaping products require Proposition 65 warnings. Further, Matthew Holian in Boston and Baltimore-based John Wellschlager are acting as national counsel for BASF Catalyst in talc powder and asbestos litigation related to its predecessor Engelhard. The firm’s client base also includes Porsche, Northrop Grumman and AM General.

[back to top]

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Co-heads of DLA Piper LLP (US)'s practice, San Diego-based Lisa Haile and Matthew Holian in Boston, specialize in patentability and licensing strategies, and product liability and mass tort, respectively. Recent highlights include obtaining issuance of multiple patents for Aegis Therapeutics’ key product areas and assisting Pfizer and Bristol-Myers Squibb (BMS) with multidistrict and state court litigation concerning alleged defects of the clients’ blockbuster anticoagulant medication Eliquis. New York-based litigator Loren Brown has been acting for Medtronic and Covidien in product liability litigation related to complications allegedly caused by some of Covidien’s implantable hernia mesh products. San Diego’s Larry Nishnick and Austin’s Aaron Fountain are names to note for corporate investment and patent litigation respectively.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to